{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:01:01Z","timestamp":1786982461479,"version":"build-2736575974"},"reference-count":88,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2024,7,24]],"date-time":"2024-07-24T00:00:00Z","timestamp":1721779200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,7,24]],"date-time":"2024-07-24T00:00:00Z","timestamp":1721779200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Key Project of Tibet Autonomous Region","award":["XZ202001ZY0044N; XZ202101ZD0002N-05"],"award-info":[{"award-number":["XZ202001ZY0044N; XZ202101ZD0002N-05"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Probiotics & Antimicro. Prot."],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s12602-024-10324-1","type":"journal-article","created":{"date-parts":[[2024,7,24]],"date-time":"2024-07-24T09:08:21Z","timestamp":1721812101000},"page":"3916-3929","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Pediococcus pentosaceus PP34 Ameliorates 5-Fluorouracil-Induced Intestinal Mucositis via Inhibiting Oxidative Stress and Restoring the Gut Microbiota"],"prefix":"10.1007","volume":"17","author":[{"given":"Yuanyuan","family":"He","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feiran","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohui","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengrong","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linxiao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shah","family":"Nawaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad Fakhar-e-Alam","family":"Kulyar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mudassar","family":"Iqbal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiakui","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,7,24]]},"reference":[{"key":"10324_CR1","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1016\/S0140-6736(19)32319-0","volume":"394","author":"E Dekker","year":"2019","unstructured":"Dekker E, Tanis PJ, Vleugels JLA et al (2019) Colorectal cancer. Lancet 394:1467\u20131480. https:\/\/doi.org\/10.1016\/S0140-6736(19)32319-0","journal-title":"Lancet"},{"key":"10324_CR2","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/S2468-1253(21)00426-X","volume":"7","author":"SG Patel","year":"2022","unstructured":"Patel SG, Karlitz JJ, Yen T et al (2022) The rising tide of early-onset colorectal cancer: a comprehensive review of epidemiology, clinical features, biology, risk factors, prevention, and early detection. Lancet Gastroenterol Hepatol 7:262\u2013274. https:\/\/doi.org\/10.1016\/S2468-1253(21)00426-X","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10324_CR3","doi-asserted-by":"publisher","first-page":"2371","DOI":"10.1001\/jama.2013.6296","volume":"309","author":"MM Hudson","year":"2013","unstructured":"Hudson MM, Ness KK, Gurney JG et al (2013) Clinical ascertainment of health outcomes among adults treated for childhood cancer. JAMA 309:2371\u20132381. https:\/\/doi.org\/10.1001\/jama.2013.6296","journal-title":"JAMA"},{"key":"10324_CR4","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/S1470-2045(18)30679-X","volume":"20","author":"E Angenete","year":"2019","unstructured":"Angenete E (2019) The importance of surgery in colorectal cancer treatment. Lancet Oncol 20:6\u20137. https:\/\/doi.org\/10.1016\/S1470-2045(18)30679-X","journal-title":"Lancet Oncol"},{"key":"10324_CR5","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1245\/s10434-009-0881-y","volume":"17","author":"NW Wilkinson","year":"2010","unstructured":"Wilkinson NW, Yothers G, Lopa S et al (2010) Long-term survival results of surgery alone versus surgery plus 5-fluorouracil and leucovorin for stage II and stage III colon cancer: pooled analysis of NSABP C-01 through C-05. A baseline from which to compare modern adjuvant trials. Ann Surg Oncol 17:959\u2013966. https:\/\/doi.org\/10.1245\/s10434-009-0881-y","journal-title":"Ann Surg Oncol"},{"key":"10324_CR6","doi-asserted-by":"publisher","first-page":"4569","DOI":"10.1200\/JCO.2006.10.4323","volume":"25","author":"DJ Sargent","year":"2007","unstructured":"Sargent DJ, Patiyil S, Yothers G et al (2007) End points for colon cancer adjuvant trials: observations and recommendations based on individual patient data from 20,898 patients enrolled onto 18 randomized trials from the ACCENT Group. J Clin Oncol 25:4569\u20134574. https:\/\/doi.org\/10.1200\/JCO.2006.10.4323","journal-title":"J Clin Oncol"},{"key":"10324_CR7","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1002\/bjs.5349","volume":"93","author":"S Manfredi","year":"2006","unstructured":"Manfredi S, Bouvier AM, Lepage C et al (2006) Incidence and patterns of recurrence after resection for cure of colonic cancer in a well defined population. Br J Surg 93:1115\u20131122. https:\/\/doi.org\/10.1002\/bjs.5349","journal-title":"Br J Surg"},{"key":"10324_CR8","doi-asserted-by":"publisher","first-page":"409","DOI":"10.3322\/caac.21731","volume":"72","author":"KD Miller","year":"2022","unstructured":"Miller KD, Nogueira L, Devasia T et al (2022) Cancer treatment and survivorship statistics, 2022. CA Cancer J Clin 72:409\u2013436. https:\/\/doi.org\/10.3322\/caac.21731","journal-title":"CA Cancer J Clin"},{"key":"10324_CR9","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1200\/JCO.2000.18.1.136","volume":"18","author":"S Giacchetti","year":"2000","unstructured":"Giacchetti S, Perpoint B, Zidani R et al (2000) Phase III multicenter randomized trial of oxaliplatin added to chronomodulated fluorouracil-leucovorin as first-line treatment of metastatic colorectal cancer. J Clin Oncol 18:136\u2013147. https:\/\/doi.org\/10.1200\/JCO.2000.18.1.136","journal-title":"J Clin Oncol"},{"key":"10324_CR10","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1016\/s0140-6736(00)02034-1","volume":"355","author":"JY Douillard","year":"2000","unstructured":"Douillard JY, Cunningham D, Roth AD et al (2000) Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trial. Lancet 355:1041\u20131047. https:\/\/doi.org\/10.1016\/s0140-6736(00)02034-1","journal-title":"Lancet"},{"key":"10324_CR11","doi-asserted-by":"publisher","first-page":"23241","DOI":"10.1038\/s41598-021-01969-x","volume":"11","author":"MMB Oliveira","year":"2021","unstructured":"Oliveira MMB, de Ara\u00fajo AA, Ribeiro SB et al (2021) Losartan improves intestinal mucositis induced by 5-fluorouracil in mice. Sci Rep 11:23241. https:\/\/doi.org\/10.1038\/s41598-021-01969-x","journal-title":"Sci Rep"},{"key":"10324_CR12","doi-asserted-by":"publisher","first-page":"G712","DOI":"10.1152\/ajpgi.00380.2020","volume":"320","author":"AT Sougiannis","year":"2021","unstructured":"Sougiannis AT, VanderVeen BN, Davis JM et al (2021) Understanding chemotherapy-induced intestinal mucositis and strategies to improve gut resilience. Am J Physiol Gastrointest Liver Physiol 320:G712\u2013G719. https:\/\/doi.org\/10.1152\/ajpgi.00380.2020","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10324_CR13","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.887048","volume":"13","author":"X Huang","year":"2022","unstructured":"Huang X, Ke K, Jin W et al (2022) Identification of genes related to 5-fluorouracil based chemotherapy for colorectal cancer. Front Immunol 13:887048. https:\/\/doi.org\/10.3389\/fimmu.2022.887048","journal-title":"Front Immunol"},{"key":"10324_CR14","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1038\/nrc1318","volume":"4","author":"ST Sonis","year":"2004","unstructured":"Sonis ST (2004) The pathobiology of mucositis. Nat Rev Cancer 4:277\u2013284. https:\/\/doi.org\/10.1038\/nrc1318","journal-title":"Nat Rev Cancer"},{"key":"10324_CR15","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1038\/sj.bmt.1702447","volume":"25","author":"NM Blijlevens","year":"2000","unstructured":"Blijlevens NM, Donnelly JP, De Pauw BE (2000) Mucosal barrier injury: biology, pathology, clinical counterparts and consequences of intensive treatment for haematological malignancy: an overview. Bone Marrow Transplant 25:1269\u20131278. https:\/\/doi.org\/10.1038\/sj.bmt.1702447","journal-title":"Bone Marrow Transplant"},{"key":"10324_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2020.105232","volume":"163","author":"L Wang","year":"2021","unstructured":"Wang L, Wang R, Wei G-Y et al (2021) Cryptotanshinone alleviates chemotherapy-induced colitis in mice with colon cancer via regulating fecal-bacteria-related lipid metabolism. Pharmacol Res 163:105232. https:\/\/doi.org\/10.1016\/j.phrs.2020.105232","journal-title":"Pharmacol Res"},{"key":"10324_CR17","doi-asserted-by":"publisher","DOI":"10.1128\/spectrum.01677-22","volume":"10","author":"B Huang","year":"2022","unstructured":"Huang B, Gui M, Ni Z et al (2022) Chemotherapeutic drugs induce different gut microbiota disorder pattern and NOD\/RIP2\/NF-\u03baB signaling pathway activation that lead to different degrees of intestinal injury. Microbiol Spectr 10:e0167722. https:\/\/doi.org\/10.1128\/spectrum.01677-22","journal-title":"Microbiol Spectr"},{"key":"10324_CR18","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.biopha.2018.08.165","volume":"108","author":"L Yuan","year":"2018","unstructured":"Yuan L, Zhang S, Li H et al (2018) The influence of gut microbiota dysbiosis to the efficacy of 5-fluorouracil treatment on colorectal cancer. Biomed Pharmacother 108:184\u2013193. https:\/\/doi.org\/10.1016\/j.biopha.2018.08.165","journal-title":"Biomed Pharmacother"},{"key":"10324_CR19","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1000879","volume":"6","author":"MJ van Vliet","year":"2010","unstructured":"van Vliet MJ, Harmsen HJM, de Bont ESJM, Tissing WJE (2010) The role of intestinal microbiota in the development and severity of chemotherapy-induced mucositis. PLoS Pathog 6:e1000879. https:\/\/doi.org\/10.1371\/journal.ppat.1000879","journal-title":"PLoS Pathog"},{"key":"10324_CR20","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1111\/jgh.14890","volume":"35","author":"C-Y Yeung","year":"2020","unstructured":"Yeung C-Y, Chiang Chiau J-S, Cheng M-L et al (2020) Modulations of probiotics on gut microbiota in a 5-fluorouracil-induced mouse model of mucositis. J Gastroenterol Hepatol 35:806\u2013814. https:\/\/doi.org\/10.1111\/jgh.14890","journal-title":"J Gastroenterol Hepatol"},{"key":"10324_CR21","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1080\/10408390903551747","volume":"51","author":"LD Prisciandaro","year":"2011","unstructured":"Prisciandaro LD, Geier MS, Butler RN et al (2011) Evidence supporting the use of probiotics for the prevention and treatment of chemotherapy-induced intestinal mucositis. Crit Rev Food Sci Nutr 51:239\u2013247. https:\/\/doi.org\/10.1080\/10408390903551747","journal-title":"Crit Rev Food Sci Nutr"},{"key":"10324_CR22","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1038\/nrgastro.2014.66","volume":"11","author":"C Hill","year":"2014","unstructured":"Hill C, Guarner F, Reid G et al (2014) Expert consensus document. The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nat Rev Gastroenterol Hepatol 11:506\u2013514. https:\/\/doi.org\/10.1038\/nrgastro.2014.66","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10324_CR23","first-page":"170","volume":"96","author":"T Wilkins","year":"2017","unstructured":"Wilkins T, Sequoia J (2017) Probiotics for gastrointestinal conditions: a summary of the evidence. Am Fam Physician 96:170\u2013178","journal-title":"Am Fam Physician"},{"key":"10324_CR24","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1038\/s41591-019-0439-x","volume":"25","author":"J Suez","year":"2019","unstructured":"Suez J, Zmora N, Segal E, Elinav E (2019) The pros, cons, and many unknowns of probiotics. Nat Med 25:716\u2013729. https:\/\/doi.org\/10.1038\/s41591-019-0439-x","journal-title":"Nat Med"},{"key":"10324_CR25","doi-asserted-by":"publisher","first-page":"2197837","DOI":"10.1080\/19490976.2023.2197837","volume":"15","author":"H Lai","year":"2023","unstructured":"Lai H, Li Y, He Y et al (2023) Effects of dietary fibers or probiotics on functional constipation symptoms and roles of gut microbiota: a double-blinded randomized placebo trial. Gut Microbes 15:2197837. https:\/\/doi.org\/10.1080\/19490976.2023.2197837","journal-title":"Gut Microbes"},{"key":"10324_CR26","doi-asserted-by":"publisher","first-page":"3081","DOI":"10.3390\/ijms24043081","volume":"24","author":"M Sikorska","year":"2023","unstructured":"Sikorska M, Antosik-W\u00f3jci\u0144ska AZ, Dominiak M (2023) Probiotics as a tool for regulating molecular mechanisms in depression: a systematic review and meta-analysis of randomized clinical trials. Int J Mol Sci 24:3081. https:\/\/doi.org\/10.3390\/ijms24043081","journal-title":"Int J Mol Sci"},{"key":"10324_CR27","doi-asserted-by":"publisher","first-page":"CD012849","DOI":"10.1002\/14651858.CD012849.pub2","volume":"2","author":"C Wallace","year":"2023","unstructured":"Wallace C, Gordon M, Sinopoulou V, Akobeng AK (2023) Probiotics for management of functional abdominal pain disorders in children. Cochrane Database Syst Rev 2:CD012849. https:\/\/doi.org\/10.1002\/14651858.CD012849.pub2","journal-title":"Cochrane Database Syst Rev"},{"key":"10324_CR28","doi-asserted-by":"publisher","first-page":"1178399","DOI":"10.3389\/fcimb.2023.1178399","volume":"13","author":"Y Cai","year":"2023","unstructured":"Cai Y, Liu P, Zhou X et al (2023) Probiotics therapy show significant improvement in obesity and neurobehavioral disorders symptoms. Front Cell Infect Microbiol 13:1178399. https:\/\/doi.org\/10.3389\/fcimb.2023.1178399","journal-title":"Front Cell Infect Microbiol"},{"key":"10324_CR29","doi-asserted-by":"publisher","first-page":"1220877","DOI":"10.3389\/fcimb.2023.1220877","volume":"13","author":"Z Chen","year":"2023","unstructured":"Chen Z, Liang W, Liang J et al (2023) Probiotics: functional food ingredients with the potential to reduce hypertension. Front Cell Infect Microbiol 13:1220877. https:\/\/doi.org\/10.3389\/fcimb.2023.1220877","journal-title":"Front Cell Infect Microbiol"},{"key":"10324_CR30","doi-asserted-by":"publisher","first-page":"46","DOI":"10.3390\/foods12010046","volume":"12","author":"M Escobar-S\u00e1nchez","year":"2022","unstructured":"Escobar-S\u00e1nchez M, Carrasco-Navarro U, Ju\u00e1rez-Castel\u00e1n C et al (2022) Probiotic properties and proteomic analysis of Pediococcus pentosaceus 1101. Foods 12:46. https:\/\/doi.org\/10.3390\/foods12010046","journal-title":"Foods"},{"key":"10324_CR31","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s12934-021-01537-y","volume":"20","author":"S Jiang","year":"2021","unstructured":"Jiang S, Cai L, Lv L, Li L (2021) Pediococcus pentosaceus, a future additive or probiotic candidate. Microb Cell Fact 20:45. https:\/\/doi.org\/10.1186\/s12934-021-01537-y","journal-title":"Microb Cell Fact"},{"key":"10324_CR32","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2021.762467","volume":"12","author":"Y Qi","year":"2021","unstructured":"Qi Y, Huang L, Zeng Y et al (2021) Pediococcus pentosaceus: screening and application as probiotics in food processing. Front Microbiol 12:762467. https:\/\/doi.org\/10.3389\/fmicb.2021.762467","journal-title":"Front Microbiol"},{"key":"10324_CR33","doi-asserted-by":"publisher","first-page":"1657","DOI":"10.1007\/s00253-021-11111-6","volume":"105","author":"L Hao","year":"2021","unstructured":"Hao L, Cheng Y, Su W et al (2021) Pediococcus pentosaceus ZJUAF-4 relieves oxidative stress and restores the gut microbiota in diquat-induced intestinal injury. Appl Microbiol Biotechnol 105:1657\u20131668. https:\/\/doi.org\/10.1007\/s00253-021-11111-6","journal-title":"Appl Microbiol Biotechnol"},{"key":"10324_CR34","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s12967-022-03235-8","volume":"20","author":"F Dong","year":"2022","unstructured":"Dong F, Xiao F, Li X et al (2022) Pediococcus pentosaceus CECT 8330 protects DSS-induced colitis and regulates the intestinal microbiota and immune responses in mice. J Transl Med 20:33. https:\/\/doi.org\/10.1186\/s12967-022-03235-8","journal-title":"J Transl Med"},{"key":"10324_CR35","doi-asserted-by":"publisher","first-page":"5607","DOI":"10.1039\/d0fo00208a","volume":"11","author":"J Huang","year":"2020","unstructured":"Huang J, Li S, Wang Q et al (2020) Pediococcus pentosaceus B49 from human colostrum ameliorates constipation in mice. Food Funct 11:5607\u20135620. https:\/\/doi.org\/10.1039\/d0fo00208a","journal-title":"Food Funct"},{"key":"10324_CR36","doi-asserted-by":"publisher","first-page":"2945","DOI":"10.3390\/foods10122945","volume":"10","author":"H Li","year":"2021","unstructured":"Li H, Xie X, Li Y et al (2021) Pediococcus pentosaceus IM96 exerts protective effects against enterohemorrhagic Escherichia coli O157:H7 infection in vivo. Foods 10:2945. https:\/\/doi.org\/10.3390\/foods10122945","journal-title":"Foods"},{"key":"10324_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.micpath.2020.104163","volume":"144","author":"H Yin","year":"2020","unstructured":"Yin H, Ye P, Lei Q et al (2020) In vitro probiotic properties of Pediococcus pentosaceus L1 and its effects on enterotoxigenic Escherichia coli-induced inflammatory responses in porcine intestinal epithelial cells. Microb Pathog 144:104163. https:\/\/doi.org\/10.1016\/j.micpath.2020.104163","journal-title":"Microb Pathog"},{"key":"10324_CR38","doi-asserted-by":"publisher","first-page":"2320283","DOI":"10.1080\/19490976.2024.2320283","volume":"16","author":"Y Liu","year":"2024","unstructured":"Liu Y, Li L, Feng J et al (2024) Modulation of chronic obstructive pulmonary disease progression by antioxidant metabolites from Pediococcus pentosaceus: enhancing gut probiotics abundance and the tryptophan-melatonin pathway. Gut Microbes 16:2320283. https:\/\/doi.org\/10.1080\/19490976.2024.2320283","journal-title":"Gut Microbes"},{"key":"10324_CR39","doi-asserted-by":"publisher","first-page":"3692","DOI":"10.1039\/d3fo04904c","volume":"15","author":"Y Wu","year":"2024","unstructured":"Wu Y, Li S, Lv L et al (2024) Protective effect of Pediococcus pentosaceus Li05 on diarrhea-predominant irritable bowel syndrome in rats. Food Funct 15:3692\u20133708. https:\/\/doi.org\/10.1039\/d3fo04904c","journal-title":"Food Funct"},{"key":"10324_CR40","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1186\/s40168-021-01071-4","volume":"9","author":"Y Chung","year":"2021","unstructured":"Chung Y, Ryu Y, An BC et al (2021) A synthetic probiotic engineered for colorectal cancer therapy modulates gut microbiota. Microbiome 9:122. https:\/\/doi.org\/10.1186\/s40168-021-01071-4","journal-title":"Microbiome"},{"key":"10324_CR41","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/s11658-021-00294-5","volume":"26","author":"S Deng","year":"2021","unstructured":"Deng S, Wu D, Li L et al (2021) TBHQ attenuates ferroptosis against 5-fluorouracil-induced intestinal epithelial cell injury and intestinal mucositis via activation of Nrf2. Cell Mol Biol Lett 26:48. https:\/\/doi.org\/10.1186\/s11658-021-00294-5","journal-title":"Cell Mol Biol Lett"},{"key":"10324_CR42","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1080\/17435390.2021.1943032","volume":"15","author":"A Hudita","year":"2021","unstructured":"Hudita A, Radu IC, Galateanu B et al (2021) Bioinspired silk fibroin nano-delivery systems protect against 5-FU induced gastrointestinal mucositis in a mouse model and display antitumor effects on HT-29 colorectal cancer cells in vitro. Nanotoxicology 15:973\u2013994. https:\/\/doi.org\/10.1080\/17435390.2021.1943032","journal-title":"Nanotoxicology"},{"key":"10324_CR43","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejps.2022.106182","volume":"173","author":"H Sun","year":"2022","unstructured":"Sun H, Zhou Y, Ma R et al (2022) Metformin protects 5-Fu-induced chemotherapy oral mucositis by reducing endoplasmic reticulum stress in mice. Eur J Pharm Sci 173:106182. https:\/\/doi.org\/10.1016\/j.ejps.2022.106182","journal-title":"Eur J Pharm Sci"},{"key":"10324_CR44","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1111\/1751-7915.13583","volume":"13","author":"X Bian","year":"2020","unstructured":"Bian X, Yang L, Wu W et al (2020) Pediococcus pentosaceus LI05 alleviates DSS-induced colitis by modulating immunological profiles, the gut microbiota and short-chain fatty acid levels in a mouse model. Microb Biotechnol 13:1228\u20131244. https:\/\/doi.org\/10.1111\/1751-7915.13583","journal-title":"Microb Biotechnol"},{"key":"10324_CR45","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1111\/1440-1681.12792","volume":"44","author":"S Kato","year":"2017","unstructured":"Kato S, Hamouda N, Kano Y et al (2017) Probiotic Bifidobacterium bifidum G9\u20131 attenuates 5-fluorouracil-induced intestinal mucositis in mice via suppression of dysbiosis-related secondary inflammatory responses. Clin Exp Pharmacol Physiol 44:1017\u20131025. https:\/\/doi.org\/10.1111\/1440-1681.12792","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"10324_CR46","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2019.116888","volume":"239","author":"J Ali","year":"2019","unstructured":"Ali J, Khan AU, Shah FA et al (2019) Mucoprotective effects of Saikosaponin-A in 5-fluorouracil-induced intestinal mucositis in mice model. Life Sci 239:116888. https:\/\/doi.org\/10.1016\/j.lfs.2019.116888","journal-title":"Life Sci"},{"key":"10324_CR47","doi-asserted-by":"publisher","first-page":"9474","DOI":"10.3390\/ijms22179474","volume":"22","author":"L Wei","year":"2021","unstructured":"Wei L, Wen X-S, Xian CJ (2021) Chemotherapy-induced intestinal microbiota dysbiosis impairs mucosal homeostasis by modulating toll-like receptor signaling pathways. Int J Mol Sci 22:9474. https:\/\/doi.org\/10.3390\/ijms22179474","journal-title":"Int J Mol Sci"},{"key":"10324_CR48","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1186\/s40168-018-0483-7","volume":"6","author":"C Panebianco","year":"2018","unstructured":"Panebianco C, Andriulli A, Pazienza V (2018) Pharmacomicrobiomics: exploiting the drug-microbiota interactions in anticancer therapies. Microbiome 6:92. https:\/\/doi.org\/10.1186\/s40168-018-0483-7","journal-title":"Microbiome"},{"key":"10324_CR49","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbcan.2020.188494","volume":"1875","author":"A Badgeley","year":"2021","unstructured":"Badgeley A, Anwar H, Modi K et al (2021) Effect of probiotics and gut microbiota on anti-cancer drugs: mechanistic perspectives. Biochim Biophys Acta Rev Cancer 1875:188494. https:\/\/doi.org\/10.1016\/j.bbcan.2020.188494","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"10324_CR50","doi-asserted-by":"publisher","first-page":"e897","DOI":"10.1097\/MPH.0000000000002023","volume":"43","author":"A Sabus","year":"2021","unstructured":"Sabus A, Merrow M, Heiden A et al (2021) Fecal microbiota transplantation for treatment of severe Clostridioides difficile colitis in a pediatric patient with non-Hodgkin lymphoma. J Pediatr Hematol Oncol 43:e897\u2013e899. https:\/\/doi.org\/10.1097\/MPH.0000000000002023","journal-title":"J Pediatr Hematol Oncol"},{"key":"10324_CR51","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.jff.2018.12.027","volume":"53","author":"LCL De Jesus","year":"2019","unstructured":"De Jesus LCL, Drumond MM, de Carvalho A et al (2019) Protective effect of Lactobacillus delbrueckii subsp. lactis CIDCA 133 in a model of 5 fluorouracil-induced intestinal mucositis. J Funct Foods 53:197\u2013207. https:\/\/doi.org\/10.1016\/j.jff.2018.12.027","journal-title":"J Funct Foods"},{"key":"10324_CR52","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.pedneo.2018.07.007","volume":"60","author":"L Huang","year":"2019","unstructured":"Huang L, Chiang Chiau JS, Cheng ML et al (2019) SCID\/NOD mice model for 5-FU induced intestinal mucositis: safety and effects of probiotics as therapy. Pediatr Neonatol 60:252\u2013260. https:\/\/doi.org\/10.1016\/j.pedneo.2018.07.007","journal-title":"Pediatr Neonatol"},{"key":"10324_CR53","doi-asserted-by":"publisher","first-page":"1238358","DOI":"10.1155\/2022\/1238358","volume":"2022","author":"R Huang","year":"2022","unstructured":"Huang R, Ai G, Zhong L et al (2022) Protective effects of oxyberberine in 5-fluorouracil-induced intestinal mucositis in the mice model. Evid Based Complement Alternat Med 2022:1238358. https:\/\/doi.org\/10.1155\/2022\/1238358","journal-title":"Evid Based Complement Alternat Med"},{"key":"10324_CR54","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1111\/hepr.13742","volume":"52","author":"Y Furuichi","year":"2022","unstructured":"Furuichi Y (2022) Measurement of spleen length and two-dimensional spleen index is comparable to spleen volumetry by computed tomography for predicting esophageal varices. Hepatol Res 52:139\u2013140. https:\/\/doi.org\/10.1111\/hepr.13742","journal-title":"Hepatol Res"},{"key":"10324_CR55","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1080\/10799893.2020.1808675","volume":"41","author":"Q Li","year":"2021","unstructured":"Li Q, Tan Y, Chen S et al (2021) Irisin alleviates LPS-induced liver injury and inflammation through inhibition of NLRP3 inflammasome and NF-\u03baB signaling. J Recept Signal Transduct Res 41:294\u2013303. https:\/\/doi.org\/10.1080\/10799893.2020.1808675","journal-title":"J Recept Signal Transduct Res"},{"key":"10324_CR56","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1080\/01635581.2017.1300289","volume":"69","author":"JM Lee","year":"2017","unstructured":"Lee JM, Chun HJ, Choi HS et al (2017) Selenium administration attenuates 5-flurouracil-induced intestinal mucositis. Nutr Cancer 69:616\u2013622. https:\/\/doi.org\/10.1080\/01635581.2017.1300289","journal-title":"Nutr Cancer"},{"key":"10324_CR57","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/s00280-010-1451-5","volume":"68","author":"Z-Q Wu","year":"2011","unstructured":"Wu Z-Q, Han X-D, Wang Y et al (2011) Interleukin-1 receptor antagonist reduced apoptosis and attenuated intestinal mucositis in a 5-fluorouracil chemotherapy model in mice. Cancer Chemother Pharmacol 68:87\u201396. https:\/\/doi.org\/10.1007\/s00280-010-1451-5","journal-title":"Cancer Chemother Pharmacol"},{"key":"10324_CR58","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1186\/s12885-019-6231-y","volume":"19","author":"JM Lee","year":"2019","unstructured":"Lee JM, Yoo IK, Lee JM et al (2019) Dipeptidyl-peptidase-4 (DPP-4) inhibitor ameliorates 5-flurouracil induced intestinal mucositis. BMC Cancer 19:1016. https:\/\/doi.org\/10.1186\/s12885-019-6231-y","journal-title":"BMC Cancer"},{"key":"10324_CR59","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2020.109883","volume":"124","author":"J Wu","year":"2020","unstructured":"Wu J, Gan Y, Li M et al (2020) Patchouli alcohol attenuates 5-fluorouracil-induced intestinal mucositis via TLR2\/MyD88\/NF-kB pathway and regulation of microbiota. Biomed Pharmacother 124:109883. https:\/\/doi.org\/10.1016\/j.biopha.2020.109883","journal-title":"Biomed Pharmacother"},{"key":"10324_CR60","doi-asserted-by":"publisher","first-page":"2333","DOI":"10.1023\/B:DDAS.0000007872.66693.6c","volume":"48","author":"S Tsunada","year":"2003","unstructured":"Tsunada S, Iwakiri R, Fujimoto K, Aw TY (2003) Chronic lipid hydroperoxide stress suppresses mucosal proliferation in rat intestine: potentiation of ornithine decarboxylase activity by epidermal growth factor. Dig Dis Sci 48:2333\u20132341. https:\/\/doi.org\/10.1023\/B:DDAS.0000007872.66693.6c","journal-title":"Dig Dis Sci"},{"key":"10324_CR61","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1016\/j.semcdb.2012.03.014","volume":"23","author":"ML Circu","year":"2012","unstructured":"Circu ML, Aw TY (2012) Intestinal redox biology and oxidative stress. Semin Cell Dev Biol 23:729\u2013737. https:\/\/doi.org\/10.1016\/j.semcdb.2012.03.014","journal-title":"Semin Cell Dev Biol"},{"key":"10324_CR62","doi-asserted-by":"publisher","first-page":"521","DOI":"10.3390\/nu9050521","volume":"9","author":"Y Wang","year":"2017","unstructured":"Wang Y, Wu Y, Wang Y et al (2017) Antioxidant properties of probiotic bacteria. Nutrients 9:521. https:\/\/doi.org\/10.3390\/nu9050521","journal-title":"Nutrients"},{"key":"10324_CR63","doi-asserted-by":"publisher","first-page":"3615","DOI":"10.1021\/jf506326t","volume":"63","author":"V Mishra","year":"2015","unstructured":"Mishra V, Shah C, Mokashe N et al (2015) Probiotics as potential antioxidants: a systematic review. J Agric Food Chem 63:3615\u20133626. https:\/\/doi.org\/10.1021\/jf506326t","journal-title":"J Agric Food Chem"},{"key":"10324_CR64","doi-asserted-by":"publisher","first-page":"3015","DOI":"10.1007\/s00253-016-8032-4","volume":"101","author":"Y Wang","year":"2017","unstructured":"Wang Y, Wu Y, Wang Y et al (2017) Bacillus amyloliquefaciens SC06 alleviates the oxidative stress of IPEC-1 via modulating Nrf2\/Keap1 signaling pathway and decreasing ROS production. Appl Microbiol Biotechnol 101:3015\u20133026. https:\/\/doi.org\/10.1007\/s00253-016-8032-4","journal-title":"Appl Microbiol Biotechnol"},{"key":"10324_CR65","doi-asserted-by":"publisher","first-page":"1022879","DOI":"10.3389\/fcimb.2022.1022879","volume":"12","author":"S Pan","year":"2022","unstructured":"Pan S, Wei H, Yuan S et al (2022) Probiotic Pediococcus pentosaceus ameliorates MPTP-induced oxidative stress via regulating the gut microbiota-gut-brain axis. Front Cell Infect Microbiol 12:1022879. https:\/\/doi.org\/10.3389\/fcimb.2022.1022879","journal-title":"Front Cell Infect Microbiol"},{"key":"10324_CR66","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1007\/s00204-024-03696-4","volume":"98","author":"K Jomova","year":"2024","unstructured":"Jomova K, Alomar SY, Alwasel SH et al (2024) Several lines of antioxidant defense against oxidative stress: antioxidant enzymes, nanomaterials with multiple enzyme-mimicking activities, and low-molecular-weight antioxidants. Arch Toxicol 98:1323\u20131367. https:\/\/doi.org\/10.1007\/s00204-024-03696-4","journal-title":"Arch Toxicol"},{"key":"10324_CR67","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1007\/s00280-008-0715-9","volume":"63","author":"PMG Soares","year":"2008","unstructured":"Soares PMG, Mota JMSC, Gomes AS et al (2008) Gastrointestinal dysmotility in 5-fluorouracil-induced intestinal mucositis outlasts inflammatory process resolution. Cancer Chemother Pharmacol 63:91\u201398. https:\/\/doi.org\/10.1007\/s00280-008-0715-9","journal-title":"Cancer Chemother Pharmacol"},{"key":"10324_CR68","doi-asserted-by":"publisher","first-page":"75","DOI":"10.2323\/jgam.62.75","volume":"62","author":"A Watanabe","year":"2016","unstructured":"Watanabe A, Kaneko C, Hamada Y et al (2016) Isolation of lactic acid bacteria exhibiting high scavenging activity for environmental hydrogen peroxide from fermented foods and its two scavenging enzymes for hydrogen peroxide. J Gen Appl Microbiol 62:75\u201382. https:\/\/doi.org\/10.2323\/jgam.62.75","journal-title":"J Gen Appl Microbiol"},{"key":"10324_CR69","doi-asserted-by":"publisher","first-page":"97","DOI":"10.12938\/bmfh.18-017","volume":"38","author":"N Yamamoto","year":"2019","unstructured":"Yamamoto N, Shoji M, Hoshigami H et al (2019) Antioxidant capacity of soymilk yogurt and exopolysaccharides produced by lactic acid bacteria. Biosci Microb Food Health 38:97\u2013104. https:\/\/doi.org\/10.12938\/bmfh.18-017","journal-title":"Biosci Microb Food Health"},{"key":"10324_CR70","doi-asserted-by":"publisher","first-page":"2684","DOI":"10.3389\/fmicb.2018.02684","volume":"9","author":"X Lin","year":"2018","unstructured":"Lin X, Xia Y, Wang G et al (2018) Lactic acid bacteria with antioxidant activities alleviating oxidized oil induced hepatic injury in mice. Front Microbiol 9:2684. https:\/\/doi.org\/10.3389\/fmicb.2018.02684","journal-title":"Front Microbiol"},{"key":"10324_CR71","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1002\/jsfa.7128","volume":"96","author":"S Ilavenil","year":"2016","unstructured":"Ilavenil S, Vijayakumar M, Kim DH et al (2016) Assessment of probiotic, antifungal and cholesterol lowering properties of Pediococcus pentosaceus KCC-23 isolated from Italian ryegrass: properties of P. pentosaceus from ryegrass. J Sci Food Agric 96:593\u2013601. https:\/\/doi.org\/10.1002\/jsfa.7128","journal-title":"J Sci Food Agric"},{"key":"10324_CR72","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.3390\/nu11061380","volume":"11","author":"JS Kim","year":"2019","unstructured":"Kim JS, Kim JH, Palaniyandi SA et al (2019) Yak-Kong Soybean (Glycine max) fermented by a novel Pediococcus pentosaceus inhibits the oxidative stress-induced monocyte\u2013endothelial cell adhesion. Nutrients 11:1380. https:\/\/doi.org\/10.3390\/nu11061380","journal-title":"Nutrients"},{"key":"10324_CR73","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1111\/bcpt.12793","volume":"121","author":"N Hamouda","year":"2017","unstructured":"Hamouda N, Sano T, Oikawa Y et al (2017) Apoptosis, dysbiosis and expression of inflammatory cytokines are sequential events in the development of 5-Fluorouracil-induced intestinal mucositis in mice. Basic Clin Pharmacol Toxicol 121:159\u2013168. https:\/\/doi.org\/10.1111\/bcpt.12793","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"10324_CR74","doi-asserted-by":"publisher","first-page":"455","DOI":"10.3389\/fcimb.2017.00455","volume":"7","author":"HL Li","year":"2017","unstructured":"Li HL, Lu L, Wang XS et al (2017) Alteration of gut microbiota and inflammatory cytokine\/chemokine profiles in 5-Fluorouracil induced intestinal mucositis. Front Cell Infect Microbiol 7:455. https:\/\/doi.org\/10.3389\/fcimb.2017.00455","journal-title":"Front Cell Infect Microbiol"},{"key":"10324_CR75","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1007\/s00432-014-1869-y","volume":"141","author":"H Lu","year":"2015","unstructured":"Lu H, Liu H, Wang J et al (2015) The chemokine CXCL9 exacerbates chemotherapy-induced acute intestinal damage through inhibition of mucosal restitution. J Cancer Res Clin Oncol 141:983\u2013992. https:\/\/doi.org\/10.1007\/s00432-014-1869-y","journal-title":"J Cancer Res Clin Oncol"},{"key":"10324_CR76","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.607881","volume":"11","author":"G Tezcan","year":"2020","unstructured":"Tezcan G, Garanina EE, Alsaadi M et al (2020) Therapeutic potential of pharmacological targeting NLRP3 inflammasome complex in cancer. Front Immunol 11:607881. https:\/\/doi.org\/10.3389\/fimmu.2020.607881","journal-title":"Front Immunol"},{"key":"10324_CR77","doi-asserted-by":"publisher","first-page":"5003","DOI":"10.3168\/jds.2019-17836","volume":"103","author":"M Hu","year":"2020","unstructured":"Hu M, Wu X, Luo M et al (2020) Lactobacillus rhamnosus FLRH93 protects against intestinal damage in mice induced by 5-fluorouracil. J Dairy Sci 103:5003\u20135018. https:\/\/doi.org\/10.3168\/jds.2019-17836","journal-title":"J Dairy Sci"},{"key":"10324_CR78","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1053\/j.gastro.2022.10.018","volume":"164","author":"D Chrysostomou","year":"2023","unstructured":"Chrysostomou D, Roberts LA, Marchesi JR, Kinross JM (2023) Gut microbiota modulation of efficacy and toxicity of cancer chemotherapy and immunotherapy. Gastroenterology 164:198\u2013213. https:\/\/doi.org\/10.1053\/j.gastro.2022.10.018","journal-title":"Gastroenterology"},{"key":"10324_CR79","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/bs.acr.2022.02.007","volume":"155","author":"HI Akbarali","year":"2022","unstructured":"Akbarali HI, Muchhala KH, Jessup DK, Cheatham S (2022) Chemotherapy induced gastrointestinal toxicities. Adv Cancer Res 155:131\u2013166. https:\/\/doi.org\/10.1016\/bs.acr.2022.02.007","journal-title":"Adv Cancer Res"},{"key":"10324_CR80","doi-asserted-by":"publisher","first-page":"005781","DOI":"10.1099\/ijsem.0.005781","volume":"73","author":"MZ Siddiqi","year":"2023","unstructured":"Siddiqi MZ, Lee JE, Jun MO et al (2023) Isolation and characterization of a novel glycoside hydrolase positive bacterial strain named Terrimonas ginsenosidimutans sp. nov. with ginsenoside-converting activity. Int J Syst Evol Microbiol 73:005781. https:\/\/doi.org\/10.1099\/ijsem.0.005781","journal-title":"Int J Syst Evol Microbiol"},{"key":"10324_CR81","doi-asserted-by":"publisher","DOI":"10.1016\/j.biortech.2022.128513","volume":"369","author":"Y-N Luan","year":"2023","unstructured":"Luan Y-N, Yin Y, Xu Y et al (2023) Simultaneous nitrification and denitrification in a novel rotating self-aerated biofilm reactor for decentralized wastewater treatment. Bioresour Technol 369:128513. https:\/\/doi.org\/10.1016\/j.biortech.2022.128513","journal-title":"Bioresour Technol"},{"key":"10324_CR82","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/19490976.2021.1900996","volume":"13","author":"A Wang","year":"2021","unstructured":"Wang A, Zhang Z, Ding Q et al (2021) Intestinal Cetobacterium and acetate modify glucose homeostasis via parasympathetic activation in zebrafish. Gut Microbes 13:1\u201315. https:\/\/doi.org\/10.1080\/19490976.2021.1900996","journal-title":"Gut Microbes"},{"key":"10324_CR83","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.fsi.2021.11.017","volume":"120","author":"M Xie","year":"2022","unstructured":"Xie M, Xie Y, Li Y et al (2022) Stabilized fermentation product of Cetobacterium somerae improves gut and liver health and antiviral immunity of zebrafish. Fish Shellfish Immunol 120:56\u201366. https:\/\/doi.org\/10.1016\/j.fsi.2021.11.017","journal-title":"Fish Shellfish Immunol"},{"key":"10324_CR84","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1038\/s41366-019-0332-1","volume":"44","author":"P Wang","year":"2020","unstructured":"Wang P, Li D, Ke W et al (2020) Resveratrol-induced gut microbiota reduces obesity in high-fat diet-fed mice. Int J Obes (Lond) 44:213\u2013225. https:\/\/doi.org\/10.1038\/s41366-019-0332-1","journal-title":"Int J Obes (Lond)"},{"key":"10324_CR85","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/19490976.2021.1880221","volume":"13","author":"T Tavella","year":"2021","unstructured":"Tavella T, Rampelli S, Guidarelli G et al (2021) Elevated gut microbiome abundance of Christensenellaceae, Porphyromonadaceae and Rikenellaceae is associated with reduced visceral adipose tissue and healthier metabolic profile in Italian elderly. Gut Microbes 13:1\u201319. https:\/\/doi.org\/10.1080\/19490976.2021.1880221","journal-title":"Gut Microbes"},{"key":"10324_CR86","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1038\/s41575-022-00631-9","volume":"19","author":"PD Cani","year":"2022","unstructured":"Cani PD, Depommier C, Derrien M et al (2022) Akkermansia muciniphila: paradigm for next-generation beneficial microorganisms. Nat Rev Gastroenterol Hepatol 19:625\u2013637. https:\/\/doi.org\/10.1038\/s41575-022-00631-9","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10324_CR87","doi-asserted-by":"publisher","first-page":"001435","DOI":"10.1099\/jmm.0.001435","volume":"70","author":"A Hasani","year":"2021","unstructured":"Hasani A, Ebrahimzadeh S, Hemmati F et al (2021) The role of Akkermansia muciniphila in obesity, diabetes and atherosclerosis. J Med Microbiol 70:001435. https:\/\/doi.org\/10.1099\/jmm.0.001435","journal-title":"J Med Microbiol"},{"key":"10324_CR88","doi-asserted-by":"publisher","first-page":"2057778","DOI":"10.1080\/19490976.2022.2057778","volume":"14","author":"L Henneke","year":"2022","unstructured":"Henneke L, Schlicht K, Andreani NA et al (2022) A dietary carbohydrate - gut Parasutterella - human fatty acid biosynthesis metabolic axis in obesity and type 2 diabetes. Gut Microbes 14:2057778. https:\/\/doi.org\/10.1080\/19490976.2022.2057778","journal-title":"Gut Microbes"}],"container-title":["Probiotics and Antimicrobial Proteins"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12602-024-10324-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12602-024-10324-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12602-024-10324-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T12:45:45Z","timestamp":1763642745000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12602-024-10324-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,24]]},"references-count":88,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["10324"],"URL":"https:\/\/doi.org\/10.1007\/s12602-024-10324-1","relation":{},"ISSN":["1867-1306","1867-1314"],"issn-type":[{"value":"1867-1306","type":"print"},{"value":"1867-1314","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,24]]},"assertion":[{"value":"8 July 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 July 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal experiment protocols conformed to the rules of the National Guidelines for Housing and Care of Laboratory Animals (China) and were performed after obtaining approval from the Institutional Animal Care and Ethics Committee of Huazhong Agricultural University (HZAUMO-2023\u20130276).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}]}}